Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ADH1B | P00325 | 2/20 | 0.39 |
| ▸ | ADH1C | P00326 | 2/20 | 0.39 |
| ▸ | ADH1A | P07327 | 2/20 | 0.39 |
| ▸ | ADH7 | P40394 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.34 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.34 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.34 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17831473 | 0.97 | TSHR (0.50) | TSHRALDH1A1CYP2C19MEN1GLA | |
| SCHEMBL13770554 | 0.92 | TSHR (0.65) | TSHRALDH1A1CYP2C19MEN1GLA | |
| SCHEMBL10181340 | 0.90 | TSHR (0.62) | TSHRALDH1A1CYP2C19ADH1BADH1C | |
| SCHEMBL22109451 | 0.90 | TSHR (0.62) | TSHRALDH1A1CYP2C19MEN1GLA | |
| SCHEMBL12011756 | 0.90 | TSHR (0.46) | TSHRALDH1A1CYP2C19MEN1GLA | |
| SCHEMBL864676 | 0.90 | TSHR (0.52) | TSHRALDH1A1CYP2C19MEN1GLA | |
| SCHEMBL2397649 | 0.89 | CYP2C19 (0.40) | TSHRALDH1A1CYP2C19MEN1GLA | |
| Hydrochloric Acid SCHEMBL4308486 | 0.87 | TSHR (0.50) | TSHRALDH1A1CYP2C19MEN1GLA | |
| SCHEMBL19504379 | 0.86 | CYP2C19 (0.38) | TSHRALDH1A1CYP2C19MEN1GLA | |
| SCHEMBL13649902 | 0.83 | CYP2C19 (0.36) | TSHRALDH1A1CYP2C19MEN1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11325111-B2 | Catalysts and methods of making the same | EXXONMOBIL RESEARCH & ENGINEERING COMPANY (US) | 2022-05-10 | — | — | US | disclosed |
| US-11111352-B2 | Methods of producing organosilica materials and uses thereof | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2021-09-07 | — | — | US | disclosed |
| US-20190194414-A1 | METHODS OF PRODUCING ORGANOSILICA MATERIALS AND USES THEREOF | EXXONMOBIL RES & ENG CO (US) | 2019-06-27 | — | — | US | disclosed |
| US-20190105647-A1 | CATALYSTS AND METHODS OF MAKING THE SAME | EXXONMOBIL RES & ENG CO (US) | 2019-04-11 | — | — | US | disclosed |
| US-9850251-B2 | Imidazole derivative used as antiviral agent and use therof in preparation of medicament | SHANDONG DANHONG PHARMACEUTICAL CO., LTD. (CN) | 2017-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11325111-B2 | Catalysts and methods of making the same | CAT, STOM, SOD1 | TSHR 4489/4885ALDH1A1 3376/4885CYP2C19 3414/4885 |
| US-20190105647-A1 | CATALYSTS AND METHODS OF MAKING THE SAME | CAT, STOM, SOD1 | TSHR 4489/4885ALDH1A1 3376/4885CYP2C19 3414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.